Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer

Azbazdar Y., Karabicici M., ERDAL BAĞRIYANIK Ş. E., ÖZHAN H. G.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, cilt.9, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 9
  • Basım Tarihi: 2021
  • Doi Numarası: 10.3389/fcell.2021.631623
  • Dergi Adı: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Wnt, frizzled, plasma membrane, cancer, lipid raft, WNT/BETA-CATENIN PATHWAY, EPITHELIAL-MESENCHYMAL TRANSITION, CLATHRIN-MEDIATED ENDOCYTOSIS, BREAST-CANCER, HEPATOCELLULAR-CARCINOMA, CELL-PROLIFERATION, BETA-CATENIN, FRIZZLED RECEPTORS, LIPID RAFTS, STEM-CELLS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Wnt signaling is one of the key signaling pathways that govern numerous physiological activities such as growth, differentiation and migration during development and homeostasis. As pathway misregulation has been extensively linked to pathological processes including malignant tumors, a thorough understanding of pathway regulation is essential for development of effective therapeutic approaches. A prominent feature of cancer cells is that they significantly differ from healthy cells with respect to their plasma membrane composition and lipid organization. Here, we review the key role of membrane composition and lipid order in activation of Wnt signaling pathway by tightly regulating formation and interactions of the Wnt-receptor complex. We also discuss in detail how plasma membrane components, in particular the ligands, (co)receptors and extracellular or membrane-bound modulators, of Wnt pathways are affected in lung, colorectal, liver and breast cancers that have been associated with abnormal activation of Wnt signaling. Wnt-receptor complex components and their modulators are frequently misexpressed in these cancers and this appears to correlate with metastasis and cancer progression. Thus, composition and organization of the plasma membrane can be exploited to develop new anticancer drugs that are targeted in a highly specific manner to the Wnt-receptor complex, rendering a more effective therapeutic outcome possible.